Select a year:

Discover our second video focus on our preclinical department

4P-Pharma is pleased to share the second video of a series of three videos made in collaboration with Entreprendre magazine in order to highlight innovative biotechnology companies. In this second video, we spotlight our company preclinical vision. Driven by the vision of combining the biology of untreated diseases with the mechanism of action of drugs, we&hellip

Read More

4P-Pharma at BIO Europe 2022!

4P-Pharma is present at BIO Europe 2022! ​Join us at the digital event. Roselina Lam, our Business Development and Licensing–in Manager, will attend the upcoming BIO Europe on October 24-26, 2022 in Leipzig, Germany! To learn more about us, our pipeline and discuss future partnership, please feel free to connect with us by e-mail or via the partnering platform.​ For further information, click here!

Read More

4P-Pharma is pleased to welcome Emmanuelle Lopez as our new CFO

4P-Pharma is delighted to welcome Emmanuelle Lopez appointed as a Chief Financial Officer. She has substantial experience and background in both pharma and biotech companies. Emmanuelle Lopez is joining our company at its best time where we are taking an important turn in our growth with the start of our clinical trials. Together, we are&hellip

Read More

4P-Pharma at BIO-EUROPE 2021

4P-Pharma is attending BIO-Europe! Join us at the digital event, October 25–28, 2021. Revital Rattenbach, our chairwoman, and Roselina Lam, our business development and licensing-in manager, participate to the event. To learn more about us and discuss future partnership, please feel free to connect with us via the partnering platform For further information, click here

Read More

4P-Pharma will attend the 10th DDIP, November 28th-29th 2019 – Barcelona, Spain

We’re glad to announce that Céline Martin, 4P-Pharma’s R&D Manager will speak during  the 10th Drug Discovery Innovation Programme (10th DDIP) organized by the World BI, November 28th-29th 2019, at Barcelona, Spain: “Pharmaceutical Development Through A Rapid Value Creation Business Model”. To learn more about 4P-Pharma, our pipeline and our partnerships, please feel free to&hellip

Read More